Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.460
+0.160 (6.96%)
At close: Mar 4, 2026, 4:00 PM EST
2.476
+0.016 (0.64%)
After-hours: Mar 4, 2026, 6:07 PM EST
BDTX Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for BDTX stock have an average target of 10.4, with a low estimate of 8.00 and a high estimate of 15. The average target predicts an increase of 322.76% from the current stock price of 2.46.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 16, 2026.
Analyst Ratings
The average analyst rating for BDTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 3 | 3 | 3 |
| Buy | 3 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +225.20% | Jan 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +265.85% | Nov 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +225.20% | Oct 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +225.20% | Sep 4, 2025 |
Financial Forecast
Revenue This Year
71.40M
Revenue Next Year
n/a
from 71.40M
EPS This Year
0.48
from -1.27
EPS Next Year
-0.64
from 0.48
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 73.5M | n/a | ||||
| Avg | 71.4M | n/a | ||||
| Low | 68.6M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.64 | -0.20 | ||||
| Avg | 0.48 | -0.64 | ||||
| Low | 0.41 | -0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.